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Abstract Background. The choice of prescribed emollients is usually based on cost and
patient preference. Differences in formulations can affect user acceptability.
Aim. To compare the physical performance, user acceptability and various product
design features of two emollient gels that are prescribed in the UK and alleged to be
therapeutically interchangeable because their formulations are described as having
the same contents of oily ingredients.
Results. We found that here are in fact significant measurable differences between
the structure and performance of the two formulations, which materially affect their
user acceptability. These differences are attributed to the use of different types of gel-
ling agents and other ingredients of differing grades/quality and concentrations, and
probably due to the formulations being made by different manufacturing processes.
We also identified other product design features that are important to user appeal,
including the type of container in which the formulations are presented, the type of
dispensing devices provided, and the nature and form of the supplied user instruc-
tions.
Conclusion. Patients and prescribers should be aware that there can be important
differences in performance and user appeal between emollients, even between prod-
ucts that, superficially, may appear to be very similar. These important performance
aspects should be characterized for new emollient introductions to encourage better
informed product selection.
Prescribers tend to recommend emollients based pri-
marily on patient preference and cost.1,2 Advanced
and innovative emollients have been developed to opti-
mize therapeutic performance and patient appeal.
Recently, emollients have emerged on the UK market
that are alleged to be interchangeable because, superfi-
cially, they appear to have similar oil compositions as
the innovator products. However, owing to other
important qualitative and quantitative differences
between their ingredients, their physical performances
and user appeal can nevertheless be very different.
We investigated this by comparing the structural
and textural properties of an innovator licensed emol-
lient gel [Doublebase Gel (DBG), PL 00173/0183; Der-
mal Laboratories, Hitchin, Hertfordshire, UK)] and a
self-certified Class I medical device emollient gel
[Zerodouble Gel (ZDG), T&R Derma, Linthwaite, Hud-
dersfield, UK]. The well-established performance and
therapeutic effectiveness of the innovator gel, DBG,
stems from the special design of its formulation in its
entirety, including the method of manufacture. One
important feature is the manner in which the emul-
sion system breaks down irreversibly in contact with
salts on the skin. This study therefore compared struc-
tural differences between the DBG and ZDG
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formulations in their normal states and after contact
with salt. We also explored the perceived importance
of various other differences between the designs of
these two products that potentially might affect their
user appeal and therapeutic usefulness.
Methods
Sample preparation
Salt-treated samples were prepared by sprinkling
2.0  0.1 g of NaCl onto 20  0.4 g of each formula-
tion, and gently mixing by folding the formulation
onto itself 10 times, using a spatula. The samples were
then left to stand for 30 min. Untreated control sam-
ples for each emulsified gel were folded in the same
manner without adding salt.
Microscopy
Approximately 20 mg of treated and control samples
of each formulation were mixed with Nile Red fluores-
cent dye. The samples were then placed on microscope
slides and pressed with coverslips for 5 s. After 1 h,
the samples were viewed under a laser microscope
(Eclipse 90i; Nikon Instruments Inc., Amsterdam, the
Netherlands) at 9 60 magnification.
Firmness/stiffness and stickiness by texture analysis
Aliquots (50 g) of treated and control samples of DBG
and ZDG were weighed into a beaker and subjected to
compression using a 35-mm diameter cylindrical
probe (TA-HDplus; Stable Microsystems, Godalming,
Surry) to measure firmness/stiffness and stickiness.
The probe compressed the sample by 15 mm distance
after an initial trigger force of 0.5 N at a rate of
0.5 mm/s. When the 15 mm target distance was
reached, the probe returned to the starting position at
10 mm/s and recorded the force required to separate
the probe from the sample. This force is an indicator
of stickiness. Samples were analysed in triplicate.
Spreadability by texture analysis
Aliquots (1.1  0.1 g) of treated and control samples
were compressed between two glass plates using pre-
determined forces of 1, 5, 20, 40 and 50 N. At each
force, the area of spread was recorded and calculated.
Different samples were used for the measurements of
spreadability at each force applied.
Product satisfaction questionnaire
With full ethics approval (University of Greenwich
ethics committee), 67 adult participants completed a
structured questionnaire asking whether they pre-
ferred either product or liked them both equally, in
respect to various product design features addressing:
(i) the physical appearance/look of the formulations,
(ii) the suitability and performance of the containers
and dispensing devices, (iii) the accompanying written
instructions and medical advice, and (iv) the handling
characteristics of the two gel formulations.
Statistical analysis
A binomial test was carried out to identify statistical
differences between any preferences between the prod-
ucts. This test was carried out separately for each
design feature, with a null hypothesis of equal prefer-
ence for the two emollients. The tests were performed
using the PROBBNML() function from an SAS data
step, so they are exact binomial probabilities. The P
values were all very much smaller than the cut-off of
0.05.
Results
Gross characteristics of gels
On visual inspection, there were noticeable differences
between the surface characteristics and consistencies
of the two emulsified gels. DBG has a smooth and
homogeneous structure, whereas ZDG is lumpy and
(a) (b)
(c) (d)
Figure 1 (a–d) Structural behaviour of Doublebase gel (DBG) and
Zerodouble gel (ZDG) in the presence of salt.
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heterogeneous. Figure 1a–d shows the appearance of
the two gel structures before and after coming into
contact with salt. The DBG structure (Fig. 1a) largely
broke down into a liquid (Fig. 1c) after contact with
salt, whereas the ZDG structure (Fig. 1b) did not break
down, and in fact appeared to curdle and become
firmer (Fig. 1d).
Microscopic characteristics of gels
Microscopic examination also revealed differences
between the two emulsion gels, both in their normal
states (Fig. 2a,e) and following salt exposure. For DBG,
the structural matrix stabilizing the oil droplets broke
down completely (Fig. 2b–d), releasing the oil from the
emulsion. For ZDG, however, microscopic examination
suggests that the emulsion structure did not break down
to the same extent and manner as DBG (Fig. 2f–h).
Firmness/stiffness and stickiness using texture analysis
Considerable differences were observed between the
two untreated formulations in terms of firmness and
stickiness. ZDG appeared to have a significantly firmer
(Fig. 3a) and stickier polymeric structure than thatof
DBG (Fig. 3b). Upon treatment with salts, the poly-
meric structure of DBG readily broke down, resulting
in extensive loss of firmness, whereas under the same
conditions the firmness of ZDG scarcely changed
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 2 (a–h) Laser microscopy images of different areas of Doublebase gel (DBG) and Zerodouble gel (ZDG) samples before and after
salt treatment obtained at 9 60 magnification.
Figure 3 (a) Firmness/stiffness and (b) stickiness indicators of
Doublebase gel (DBG) and Zerodouble gel (ZDG) before and after
exposure to salt. ZDG* and DBG* indicate salt-treated samples.
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(Fig. 3a). Both gels appeared to lose their stickiness
once exposed to salt.
Spreadability
Notable differences were observed between the two
gels in terms of spreadability (Fig. 4). DBG spread
more easily than ZDG, and even more so after expo-
sure to salt. Interestingly, no such effect was observed
for ZDG, as there was no substantial difference
between ZDG samples before and after salt treatment.
Product satisfaction questionnaire
Of the 67 participants who were screened and com-
pleted the study, 26 were men and 41 were women.
Most participants (77.6%) were in the 18–30 age
group. The product satisfaction questionnaire results
are presented in Table 1. The results showed that
> 88% of subjects reported that the look of the DBG
formulation was smoother/more uniform, appeared to
be of a better quality and looked more appealing to
use, while 89.6% said they would prefer the DBG for-
mulation for long-term use and > 79% of subjects felt
that the DBG pump presentation looked more conve-
nient, more hygienic, easier to use and more suitable
for medicinal products of this sort than the squeeze-
bottle presentation used by ZDG. When asked which
user instructions encouraged the most patient benefit
from using the product and contained the most helpful
advice on how to look after dry skin, over 68% of sub-
jects favoured the information leaflet supplied with
DBG rather than the ‘peel and read’ label supplied
with ZDG. In addition, 74.6% reported that they pre-
ferred the handling characteristics of the DBG formula-
tion. All the binomial tests were highly statistically
significant (P < 0.001).
Discussion
Emollients are available in various formulation types,
including emulsified creams, ointments, lotions and
gels.3 They perform a crucial role in the treatment
and management of dry skin conditions such as
eczema and psoriasis.4
The sensory profile of leave-on emollients has to be
cosmetically acceptable in order to encourage patients
to use them properly, and emulsified gel formulations
Figure 4 Spreadability of Doublebase gel (DBG) and Zerodouble
gel (ZDG) before and after exposure to salt.
Table 1 Product Satisfaction Questionnaire summary table.
Question and options
DBG ZDG Both
n % n % n %
(1) Physical appearance/look of the two formulations
(a) Which one do you prefer? 61 91.0 1 1.5 5 7.5
(b) Which one looks like it has a smoother, more uniform appearance (i.e. less lumpy)? 65 97.0 1 1.5 1 1.5
(c) Which one looks the best quality? 59 88.1 1 1.5 7 10.4
(d) Which one looks the most appealing to use? 62 92.5 1 1.5 4 6.0
(e) Over a long period of time which one would you prefer to use? 60 89.6 3 4.5 4 6.0
The suitability and performance of their containers and dispensing devices
(a) Which bottle and dispenser looks the most convenient to handle in use? 60 89.6 6 9.0 1 1.5
(b) Which bottle and dispenser looks the most hygienic? 53 79.1 11 16.4 3 4.5
(c) Which bottle and dispenser looks the easiest to use? 60 89.6 5 7.5 2 3.0
(d) Which bottle and dispenser looks the most suitable for a medicinal product? 56 83.6 9 13.4 2 3.0
The written instructions and medical advice supplied with the products
(a) Which leaflet is likely to encourage the most patient benefit from using the emollient? 46 68.7 12 17.9 9 13.4
(b) Which leaflet includes the most helpful healthcare advice on how to look after dry skin? 61 91.0 4 6.0 2 3.0
The handling characteristics of the two formulations
(a) Which cream would you prefer to use? 50 74.6 7 10.4 10 14.9
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such as those tested here are popular because of their
relatively nongreasy feel.3 It is very important that
emollients are formulated to ensure they are appealing
for patients to use properly and thus achieve their full
clinical benefit.5,6
Oil-in-water (O/W) emulsions of the sort studied
here use various types of gelling agents. Carbomers
provide both gelling and emulsifying properties,7,8 and
thereby confer appropriate structure/viscosity to make
the formulation convenient to dispense, and to physi-
cally stabilize dispersion of the oil droplets. In addition,
some types of carbomer have a high propensity to
deconstruct once applied to the skin, and this property
can provide important performance advantages for the
formulation.9 The breakdown of the carbomer gel
structure is influenced by both the shear forces applied
when spreading it over the skin and by the interaction
of the formulation with salts on the skin.7 Ideally, this
deconstruction both reduces the viscosity of the gel
and results in separation of the oil and aqueous
phases, allowing the emollient (oily) ingredients to be
spread easily and form a uniform occlusive barrier
over the skin surface.10 In addition, if the phase sepa-
ration is irreversible, this also serves to prolong emol-
lient retention on the skin by rendering the oily
ingredients more resistant to re-emulsification when
washing/bathing.11,12
When compared in their normal states, the DBG for-
mulation looked smoother and more homogeneous,
and was less firm and sticky compared with ZDG. In
addition, after coming into contact with salts, the DBG
emulsion broke down more readily and substantially,
became less firm and spread more readily than ZDG.
These contrasting characteristics and performances,
both in their normal state and in contact with salts,
amply demonstrate that the structures of these two
gels are indeed very different. These measured
differences also translated into the DBG formulation
being significantly more appealing to most of the test-
ing panel.
As explained above, the observed differences in per-
formance may be partly attributed to the differing gel-
ling agents used, as different grades of carbomer
behave differently (Table 2). The differences are also
likely to be influenced by the product formulation, if
they contain other ingredients of differing grades/qual-
ity and concentrations. They are almost certainly
made by different manufacturing processes, and it is
known that even the order in which ingredients are
added can influence product performance. Other
researchers have observed that for topically applied
dosage forms, small changes in the formulation or
manufacturing process can significantly affect both
quality and efficacy.13–16 Performance differences have
also been attributed to other factors such as occlusiv-
ity, pH, viscosity, droplet size, partition coefficients and
the ionic nature of ingredients. Bearing in mind that
emollients are designed to produce an oily, partially
occlusive film over the surface of the skin and fill the
interstices between the desquamating corneocytes
abundant in dry skin conditions, their occlusivity is
bound to be influenced by the viscosity, molecular
weight and spreading characteristics of the formula-
tion.17 Changes in viscosity, for example, can alter
occlusivity and skin retention of the dosage form and
even percutaneous absorption.15 Another important
consideration is the effect of the formulation on skin
pH. Some formulation excipients can increase the pH
of the skin, resulting in skin barrier damage,18
whereas other ingredients can have beneficial effects
by decreasing skin pH19 and promoting the skin’s acid
mantle. For example, the skin’s innate antimicrobial
properties are optimal at acidic pH, as Staphylococcus
and other pathogenic bacteria favour neutral pH and
are inhibited in an acidic environment.20 Additionally,
in an acidic environment, normal desquamation of the
stratum corneum is a controlled process regulated by
the enzymes kallikreins 5 and 7.21 However, at higher
pH, desquamation of skin cells can run out of control,
damaging the stratum corneum barrier.20
For topically applied licensed medicines, there is uni-
versal acceptance that two ostensibly similar formula-
tions cannot be assumed to be therapeutically
equivalent. Indeed, this important principle explains
why regulatory authorities require generic manufac-
turers to demonstrate that their products are indeed
bioequivalent to the innovator formulation. This is
very important for topically applied dosage forms, as
differing physicochemical characteristics are known to
Table 2 Composition of Doublebase and Zerodoublegels.
Function DBG ZDG
Emollients Isopropyl myristate 15%;
liquid paraffin 15%
Isopropyl myristate 15%;
liquid paraffin 15%
Preservative Phenoxyethanol Phenoxyethanol
Humectant Glycerol Glycerin
Emulsifier Carbomer Acrylates
Emulsifier/
SWA
Sorbitan laurate Sorbitan laurate
pH modifier Triethanolamine Triethanolamine
Water base Purified water Purified water
DBG, Doublebase gel; SWA, surface-wetting agent; ZDG,
Zerodouble gel.
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render ostensibly similar formulations therapeutically
nonequivalent.16 The performance differences reported
here confirm this important principle. In stark con-
trast, however, for self-certified Class I medical devices,
there is no independent regulatory assessment of their
quality, safety or effectiveness, and the important mat-
ter of therapeutic equivalence can be completely
ignored. This is something that regulatory authorities,
healthcare professionals, prescribers and patients
should take into consideration, because important per-
formance differences do exist, even between formula-
tions that, superficially, may seem to be very similar.
In addition to these important formulation differ-
ences, other product design features were found to sig-
nificantly influence the user appeal and acceptability
of DBG and ZDG. The DBG pump pack presentation
was significantly more popular than the ZDG squeeze
bottle, in terms of convenience, hygiene and ease of
use. Although not tested in our study, leachates from
certain types of plastic containers are also known to
affect the biocompatibility of topical dosage forms,
especially for patients with sensitive skin. It is also
notable that two-thirds of users felt that the more
comprehensive style of patient instruction leaflet sup-
plied with DBG was likely to encourage the most
patient benefit.
Conclusion
By combining both objective instrumental measure-
ments and users’ subjective assessments of product
performance and acceptability, we have demonstrated
important differences between two prescribed emollient
gels that are alleged to have the same oil content and
apparently comparable lists of ingredients. It is there-
fore important to recognize that emollients from differ-
ent manufacturers are not the same as one
another, and for prescribing purposes should not be
grouped into a ’class’ and regarded as being inter-
changeable. When choosing between gel emollients,
patients and prescribers should be aware that there
can be important performance differences, even
between products that, superficially, may appear to be
very similar. The performance of new emollient intro-
ductions should be properly characterized in order to
inform product selection.
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